$621M Amgen Settlement Released After Relators Agree To Share $8M
NEW YORK — A $612 million False Claims Act settlement with drug maker Amgen Inc. has been released from three years’ in escrow after two whistle-blowers agreed to dismiss their appeal...To view the full article, register now.
Already a subscriber? Click here to view full article